HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yanping Ding Selected Research

Lasers (Laser)

1/2017Precision combination therapy for triple negative breast cancer via biomimetic polydopamine polymer core-shell nanostructures.
2/2015"Triple-punch" strategy for triple negative breast cancer therapy with minimized drug dosage and improved antitumor efficacy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yanping Ding Research Topics

Disease

24Neoplasms (Cancer)
02/2021 - 08/2009
3Inflammation (Inflammations)
01/2020 - 03/2010
3Triple Negative Breast Neoplasms
01/2017 - 02/2015
3Atherosclerosis
08/2012 - 12/2007
2Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2020 - 12/2019
2Reperfusion Injury
01/2020 - 08/2012
2Neoplasm Metastasis (Metastasis)
11/2019 - 01/2018
2Melanoma (Melanoma, Malignant)
01/2018 - 12/2011
2Breast Neoplasms (Breast Cancer)
02/2016 - 10/2012
2Type 2 Diabetes Mellitus (MODY)
01/2014 - 10/2010
1Multiple Myeloma
01/2022
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2020
1Retinoblastoma (Glioblastoma, Retinal)
08/2020
1Infarction (Infarctions)
01/2020
1Insulin Resistance
01/2020
1Brain Ischemia (Cerebral Ischemia)
01/2020
1Brain Edema (Cerebral Edema)
01/2020
1Vascular Tissue Neoplasms
01/2019
1AIDS-Related Complex (ARC)
12/2018
1Oral Leukoplakia
09/2017
1Mouth Neoplasms (Oral Cancer)
09/2017
1Hepatitis E
09/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
02/2016
1Fibrosis (Cirrhosis)
02/2016
1Hyperthermia
02/2015
1Hypoxia (Hypoxemia)
10/2012
1Lymphatic Metastasis
10/2012

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
01/2017 - 07/2013
5Peptides (Polypeptides)IBA
11/2019 - 10/2015
4Chimeric Antigen ReceptorsIBA
02/2021 - 12/2019
3Small Interfering RNA (siRNA)IBA
01/2018 - 08/2009
2Proteins (Proteins, Gene)FDA Link
08/2020 - 10/2010
2Biological ProductsIBA
01/2020 - 01/2017
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 07/2018
2Caspase 3 (Caspase-3)IBA
09/2017 - 08/2012
2AntibodiesIBA
10/2012 - 10/2010
2CytokinesIBA
10/2010 - 03/2010
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2022
1Cyclin DIBA
08/2020
1E2F1 Transcription FactorIBA
08/2020
1Cyclin EIBA
08/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
08/2020
1Superoxide DismutaseIBA
08/2020
1Malondialdehyde (Propanedial)IBA
08/2020
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2020
1Excitatory Amino AcidsIBA
01/2020
1PotassiumIBA
01/2020
1AntioxidantsIBA
01/2020
1PPAR gammaIBA
01/2020
1Antihypertensive Agents (Antihypertensives)IBA
01/2020
1SiliconIBA
01/2019
1Antineoplastic Agents (Antineoplastics)IBA
01/2019
1Dopamine (Intropin)FDA LinkGeneric
01/2019
1GhrelinIBA
12/2018
1Polylactic Acid-Polyglycolic Acid CopolymerIBA
07/2018
11- cyclohexyl- 2- (5H- imidazo(5,1- a)isoindol- 5- yl)ethanolIBA
01/2018
12,3-dimethylmaleic anhydrideIBA
01/2018
1LigandsIBA
01/2018
1Tryptophan (L-Tryptophan)FDA Link
01/2018
1Therapeutic UsesIBA
01/2018
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
09/2017
1deoxyuridine triphosphateIBA
09/2017
1SurvivinIBA
09/2017
1PolymersIBA
01/2017
1polydopamineIBA
01/2017
1Biomarkers (Surrogate Marker)IBA
01/2017
1Drug CombinationsIBA
01/2017
1VaccinesIBA
09/2016
1GoldIBA
09/2016
1tyrosine receptor (receptor, tyrosine)IBA
04/2016
1Phosphotransferases (Kinase)IBA
04/2016
1CaspasesIBA
04/2016
1Mitogen-Activated Protein KinasesIBA
04/2016
1ErbB Receptors (EGF Receptor)IBA
04/2016
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2016
1human ERBB2 proteinIBA
04/2016
1Liposomes (Liposome)IBA
02/2016
1GemcitabineFDA Link
02/2016
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
02/2016
1CyclodextrinsIBA
02/2016
1pirfenidoneIBA
02/2016
1CollagenIBA
02/2016
1arginyl-glycyl-aspartic acidIBA
02/2016
1PorphyrinsIBA
02/2016
1MicellesIBA
02/2016
1Focal Adhesion Protein-Tyrosine KinasesIBA
10/2015
1Oxygen (Dioxygen)IBA
12/2012
1Vascular Endothelial Growth Factor CIBA
10/2012
1Chemotactic FactorsIBA
10/2012
1Chemokine ReceptorsIBA
10/2012
1ChemokinesIBA
10/2012
1matrigelIBA
09/2012
1NucleolinIBA
09/2012
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
09/2012

Therapy/Procedure

14Therapeutics
10/2020 - 03/2010
3Drug Therapy (Chemotherapy)
07/2018 - 02/2015
2Immunotherapy
02/2021 - 01/2018
2Lasers (Laser)
01/2017 - 02/2015
2Photothermal Therapy
02/2016 - 02/2015
1Intravenous Injections
01/2019